Integer (NYSE:ITGR) Stock Price Passes Above 200 Day Moving Average – Here’s What Happened

Shares of Integer Holdings Corporation (NYSE:ITGR) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $85.47 and traded as high as $94.40. Integer shares last traded at $93.0490, with a volume of 261,890 shares traded.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Zacks Research downgraded Integer from a “hold” rating to a “strong sell” rating in a research note on Monday, May 11th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Integer in a research note on Thursday, June 18th. Citigroup lifted their target price on Integer from $89.00 to $92.00 and gave the stock a “neutral” rating in a report on Thursday, May 28th. Finally, Piper Sandler reissued an “overweight” rating and issued a $97.00 price target (up from $87.00) on shares of Integer in a research note on Friday, May 1st. Four research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Integer presently has a consensus rating of “Hold” and an average price target of $98.71.

Integer Price Performance

The company has a debt-to-equity ratio of 0.77, a current ratio of 3.75 and a quick ratio of 2.38. The firm has a market capitalization of $3.16 billion, a price-to-earnings ratio of 23.20, a PEG ratio of 2.18 and a beta of 0.66. The business’s fifty day simple moving average is $89.18 and its 200 day simple moving average is $85.47.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing the consensus estimate of $1.21 by ($0.01). The company had revenue of $439.58 million for the quarter, compared to analyst estimates of $426.48 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. Integer’s revenue for the quarter was up .5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. On average, research analysts forecast that Integer Holdings Corporation will post 6.04 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in ITGR. William Blair Investment Management LLC bought a new stake in shares of Integer during the third quarter worth about $28,459,000. Heartland Advisors Inc. lifted its position in Integer by 506.8% in the 4th quarter. Heartland Advisors Inc. now owns 242,715 shares of the medical equipment provider’s stock valued at $19,036,000 after acquiring an additional 202,715 shares in the last quarter. Magnetar Financial LLC bought a new position in Integer in the 3rd quarter valued at about $1,890,000. Tudor Investment Corp ET AL boosted its stake in Integer by 50,787.5% during the 3rd quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock valued at $28,606,000 after purchasing an additional 29,442,029 shares during the last quarter. Finally, Jennison Associates LLC acquired a new position in Integer during the 4th quarter valued at about $1,036,000. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.